Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | chromobox protein 1 | 0.0073 | 0.3412 | 0.4745 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0067 | 0.2899 | 0.5126 |
Echinococcus granulosus | tar DNA binding protein | 0.0067 | 0.2899 | 0.3405 |
Plasmodium vivax | thioredoxin reductase, putative | 0.005 | 0.1594 | 0.5 |
Echinococcus granulosus | chromobox protein 1 | 0.0073 | 0.3412 | 0.4745 |
Trichomonas vaginalis | CAMK family protein kinase | 0.01 | 0.5425 | 1 |
Toxoplasma gondii | thioredoxin reductase | 0.005 | 0.1594 | 0.5 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0126 | 0.7491 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.01 | 0.5425 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.0073 | 0.3412 | 0.629 |
Echinococcus multilocularis | chromobox protein 1 | 0.0073 | 0.3412 | 0.4745 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0049 | 0.1552 | 0.286 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0067 | 0.2899 | 0.4384 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0073 | 0.3412 | 0.6117 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0114 | 0.6513 | 0.8342 |
Loa Loa (eye worm) | thioredoxin reductase | 0.005 | 0.1594 | 0.2611 |
Trichomonas vaginalis | chromobox protein, putative | 0.0044 | 0.1167 | 0.2151 |
Brugia malayi | TAR-binding protein | 0.0067 | 0.2899 | 0.4384 |
Trichomonas vaginalis | chromobox protein, putative | 0.0044 | 0.1167 | 0.2151 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.01 | 0.5425 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0926 | 0.1322 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.2899 | 0.1492 |
Schistosoma mansoni | chromobox protein | 0.0073 | 0.3412 | 0.2108 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0114 | 0.6513 | 0.8342 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0126 | 0.7491 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.2899 | 0.1492 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.01 | 0.5425 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.01 | 0.5425 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0067 | 0.2899 | 0.5126 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.01 | 0.5425 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0041 | 0.0926 | 0.1707 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0126 | 0.7491 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0114 | 0.6513 | 0.8342 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0041 | 0.0926 | 0.1707 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0041 | 0.0926 | 0.1322 |
Brugia malayi | Thioredoxin reductase | 0.005 | 0.1594 | 0.1485 |
Echinococcus multilocularis | chromobox protein 1 | 0.0073 | 0.3412 | 0.4745 |
Brugia malayi | glutathione reductase | 0.005 | 0.1594 | 0.1485 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.01 | 0.5425 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.01 | 0.5425 | 1 |
Brugia malayi | Heterochromatin protein 1 | 0.0073 | 0.3412 | 0.5526 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0114 | 0.6513 | 0.8342 |
Trichomonas vaginalis | CAMK family protein kinase | 0.01 | 0.5425 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0067 | 0.2899 | 0.5126 |
Schistosoma mansoni | chromobox protein | 0.0073 | 0.3412 | 0.2108 |
Trichomonas vaginalis | CAMK family protein kinase | 0.01 | 0.5425 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.01 | 0.5425 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.2899 | 0.1492 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0049 | 0.1552 | 0.286 |
Echinococcus multilocularis | tar DNA binding protein | 0.0067 | 0.2899 | 0.3405 |
Plasmodium falciparum | thioredoxin reductase | 0.005 | 0.1594 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.01 | 0.5425 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.2899 | 0.1492 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0044 | 0.1167 | 0.1786 |
Trichomonas vaginalis | chromobox protein, putative | 0.0073 | 0.3412 | 0.629 |
Trichomonas vaginalis | CAMK family protein kinase | 0.01 | 0.5425 | 1 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.01 | 0.5425 | 1 |
Giardia lamblia | Kinase, PLK | 0.01 | 0.5425 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.01 | 0.5425 | 1 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0114 | 0.6513 | 0.8342 |
Plasmodium vivax | glutathione reductase, putative | 0.005 | 0.1594 | 0.5 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.01 | 0.5425 | 1 |
Trypanosoma brucei | polo-like protein kinase | 0.01 | 0.5425 | 1 |
Brugia malayi | RNA binding protein | 0.0067 | 0.2899 | 0.4384 |
Plasmodium falciparum | glutathione reductase | 0.005 | 0.1594 | 0.5 |
Mycobacterium tuberculosis | Probable reductase | 0.0114 | 0.6513 | 0.8342 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.2899 | 0.1492 |
Schistosoma mansoni | serine/threonine protein kinase | 0.01 | 0.5425 | 0.4519 |
Loa Loa (eye worm) | glutathione reductase | 0.005 | 0.1594 | 0.2611 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0126 | 0.7491 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.